China NMPA Product Recall - Compound Liver Extract Tablets (Capsules)
China NMPA product recall for Compound Liver Extract Tablets (Capsules) by Changzhi Sanbao Biochemical Pharmaceutical Co., Ltd. published December 25, 2015. Recall level: . The National Medical Products Administration (NMPA), through its State Food and Drug Administration
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Compound Liver Extract Tablets (Capsules) by Changzhi Sanbao Biochemical Pharmaceutical Co., Ltd. published December 25, 2015. Recall level: . The National Medical Products Administration (NMPA), through its State Food and Drug Administration
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox